ATI RN
Cardiovascular Inflammation Drug Questions
Question 1 of 5
Tick the drug which belongs to nonnucleoside reverse transcriptase inhibitors:
Correct Answer: C
Rationale: Step-by-step rationale: 1. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) bind to the enzyme reverse transcriptase. 2. Nevirapine is an NNRTI that inhibits HIV-1 reverse transcriptase. 3. Zidovudine (A) is a nucleoside reverse transcriptase inhibitor. 4. Vidarabine (B) is a nucleoside analog antiviral medication. 5. Gancyclovir (D) is a nucleoside analog antiviral used for herpesvirus infections. Summary: Choice C (Nevirapine) is the correct answer as it belongs to the class of NNRTIs by inhibiting reverse transcriptase enzyme. Choices A, B, and D are incorrect as they belong to the class of nucleoside analog antivirals, not NNRTIs.
Question 2 of 5
Which of the following pairs of drugs were most likely administered?
Correct Answer: B
Rationale: The correct answer is B, Diazoxide and hydralazine. Diazoxide is a vasodilator used to treat hypertension emergencies, while hydralazine is also a vasodilator commonly used for hypertensive crises. Both drugs have fast-acting properties and are often administered together to rapidly reduce blood pressure. A (Labetalol and prazosin) is incorrect because Labetalol is a beta-blocker and prazosin is an alpha-blocker, which are not commonly administered together for hypertensive emergencies. C (Clonidine and captopril) is incorrect because Clonidine is a centrally acting alpha-2 agonist and captopril is an ACE inhibitor, which are not typically used together for acute hypertension. D (Nitroprusside and esmolol) is incorrect because Nitroprusside is a potent vasodilator and esmolol is a beta-blocker, but they are not usually administered together
Question 3 of 5
Activation of endothelin receptor ETA leads to
Correct Answer: D
Rationale: Rationale: Activation of endothelin receptor ETA leads to vasoconstriction, bronchoconstriction, and aldosterone release, making option D, "All of the above," the correct answer. Endothelin is a potent vasoconstrictor produced by endothelial cells. When it binds to ETA receptors on smooth muscle cells, it causes vasoconstriction by stimulating the contraction of these cells, leading to increased peripheral resistance and blood pressure. Option A, vasoconstriction, is directly related to the activation of endothelin receptor ETA, as explained above. Option B, bronchoconstriction, is not a direct effect of endothelin receptor activation. Instead, bronchoconstriction is mainly mediated by other receptors such as muscarinic receptors in the airway smooth muscles. Option C, aldosterone release, is also not directly linked to endothelin receptor activation. Aldosterone release is primarily regulated by the renin-angiotensin-aldosterone system in response to factors such as blood volume and sodium levels. In an educational context, understanding the effects of endothelin receptor activation is crucial in pharmacology, particularly in the development of drugs targeting the cardiovascular system. Students studying cardiovascular pharmacology should grasp the specific mechanisms through which different receptors mediate physiological responses to design effective therapeutic interventions for conditions involving cardiovascular inflammation.
Question 4 of 5
In heart, potassium channels determine
Correct Answer: D
Rationale: In the heart, potassium channels play a crucial role in various aspects of cardiac function. The correct answer, option D, "All of the above," is correct because potassium channels determine pacemaker function, resting potential, and action potential duration in the heart. 1. Pacemaker function: Potassium channels help regulate the pacemaker function of the heart by contributing to the repolarization phase of the action potential in the sinoatrial (SA) node, the natural pacemaker of the heart. This repolarization is essential for setting the rhythm of the heart. 2. Resting potential: Potassium channels are involved in maintaining the resting membrane potential of cardiac myocytes. They allow potassium ions to move out of the cell, contributing to the negative charge inside the cell during the resting phase. 3. Action potential duration: Potassium channels are responsible for the repolarization phase of the cardiac action potential. The efflux of potassium ions through these channels helps in restoring the membrane potential after depolarization, thus determining the duration of the action potential. Now, let's discuss why the other options are incorrect: - Option A, Pacemaker function: While potassium channels do influence pacemaker function, this is not their sole role in the heart. They are also involved in other aspects of cardiac electrophysiology, as mentioned above. - Option B, Resting potential: While potassium channels do contribute to maintaining the resting potential of cardiac cells, this is not the only function they perform. They are also crucial in determining action potential duration and pacemaker function. - Option C, Action potential duration: While potassium channels do affect action potential duration, they are not limited to this function alone. As discussed earlier, they also play a role in pacemaker function and maintaining the resting potential. Educational context: Understanding the role of potassium channels in cardiac electrophysiology is fundamental in comprehending how the heart functions and how various drugs targeting these channels can impact cardiac activity. This knowledge is essential for healthcare professionals, especially those involved in cardiology and pharmacology, to make informed decisions regarding the management of cardiovascular conditions.
Question 5 of 5
Cardiac glycoside consists of
Correct Answer: B
Rationale: The correct answer is B) A steroid combined with sugar residue. Cardiac glycosides are a class of drugs commonly used to treat heart conditions like congestive heart failure and atrial fibrillation. The most well-known cardiac glycoside is digoxin. These drugs work by inhibiting the sodium-potassium pump in cardiac myocytes, leading to an increase in intracellular calcium levels, which strengthens the force of the heart's contractions. The correct option B) accurately describes the structure of cardiac glycosides. They consist of a steroid nucleus, which is the active pharmacological component responsible for their therapeutic effects, combined with a sugar residue. This unique structure allows cardiac glycosides to exert their specific actions on the heart muscle. Options A, C, and D are incorrect. Option A (Aminoacids and sugar) and Option C (A polypeptide and sugar) do not accurately represent the typical structure of cardiac glycosides. Cardiac glycosides do not contain amino acids or polypeptides in their structure. Option D (None of the above) is incorrect as well because the correct structure of cardiac glycosides is indeed a steroid combined with a sugar residue. Understanding the chemical structure of drugs, especially important classes like cardiac glycosides, is crucial for healthcare professionals to comprehend their mechanisms of action, potential side effects, and therapeutic uses. This knowledge enables healthcare providers to make informed decisions about drug therapy and ensure patient safety and optimal outcomes.